Katherine Stueland

Katherine Stueland is the Chief Executive Officer of Sema4, a patient-centered health intelligence company.1 She joined Sema4 as CEO in 2022 following the company's acquisition of GeneDx, where she previously served as President and CEO.12

Career Highlights

• Over 25 years of experience in the healthcare industry12
• Former Chief Commercial Officer at Invitae2
• Led GeneDx through a significant transformation, nearly tripling the number of patients sequenced to 700,000 exomes and genomes2
• Recognized as one of the most influential people in biotech by Fierce Pharma in 20232

Expertise

Stueland has dedicated her career to transforming healthcare through patient-centric businesses.2 Her expertise includes:

• Leadership in genomic testing and health intelligence
• Corporate brand transformations
• Commercialization of transformational technologies
• Strategies to evolve healthcare standards

Education and Personal Interests

• Bachelor's degree in Science and English Literature from Miami University, Oxford, Ohio (1997)2
• Serves on the JED Foundation Leadership Council, focusing on teen and young adult mental health2
• Passionate about mentoring women in leadership and creating human-centric business strategies2

Katherine Stueland's LinkedIn profile can be found at linkedin.com/in/katherine-stueland-4830512.3